Updates in The Management of Ob-Gyn Emergencies: January 2019
Updates in The Management of Ob-Gyn Emergencies: January 2019
Updates in The Management of Ob-Gyn Emergencies: January 2019
net/publication/331032286
CITATIONS READS
0 1,184
6 authors, including:
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Antonio Ragusa on 19 February 2019.
a b
Fig. 33.1 A case of adnexal torsion. The ovary is enlarged, the stroma is heterogeneous (a).The swollen salpinx can be seen medial to the ovary
(b). Courtesy of Daniela Giuliani, MD
33 Updates in the Management of Ob-Gyn Emergencies 485
since it may collapse after cyst rupture. Checking human into the endometrial cavity can identify the extent of intra-
chorionic gonadotropin is useful in order to exclude ectopic cavitary fibroids [32].
pregnancy. Ruptured ovarian cysts do occur in pregnant Magnetic resonance imaging (MRI) with gadolinium
women, but ectopic pregnancy is more likely to be life- contrast can provide information on devascularized (degen-
threatening than cyst rupture and should be excluded first. erated) fibroids and the relationship of fibroids to the endo-
metrial and serosal surfaces. This relationship influences the
Management choice among uterine-sparing treatment options [31].
For women with an uncomplicated rupture of an ovarian Possible complications of uterine fibroids include colli-
cyst, the observation rather than surgical intervention is rec- quative necrosis and torsion [32, 33]. Colliquative necrosis
ommended. These patients can usually be managed as outpa- occurs more frequently during pregnancy due to the rapid
tients as long as they are hemodynamically stable without a growth of the fibroid, which makes the blood supply that
significant drop in hematocrit. They should return if increased reaches the fibroid insufficient [32, 33]. The said condition
pain or light-headedness occurs. Oral analgesia is given as can result in intense localized abdominal pain, mild leukocy-
needed. Non-hemorrhagic cyst fluid is usually reabsorbed tosis, and less frequently hyperpyrexia, nausea, and sickness.
within 24 h and symptoms typically resolve within a few The diagnosis becomes suspected on the basis of clinical and
days. Follicular and corpus luteum cysts account for most of ultrasound findings [26, 32]. The latter can show the colli-
these cases. quative necrosis of the fibroid, which has irregular non-vas-
Laparoscopic surgery, rather than laparotomy, is per- cularized hypoechoic areas with regard to myomas, along
formed to control a hemorrhage if the patient’s clinical con- with peripheral vascularization with high impedance
dition is unstable [23]. (pseudo-capsule) and pain caused by the pressure of the
In pregnant women, the rupture of an ovarian cyst is most ultrasound probe [10]. Adnexal torsion, appendix abscess,
likely to occur in the first or early second trimester. and adnexal abscess are to be considered in differential
Conservative management is preferable in pregnancy, as for diagnosis.
nonpregnant patients. If surgery is necessary due to pain or Another possible complication is the torsion of peduncu-
hemorrhage, laparoscopy is a reasonable approach [24]. lated subserous myoma with consequent necrosis. This
causes acute abdominal pain.
The nature of symptoms leads to the choice of therapy.
33.1.2 Uterine Fibroids There is no evidence to support routine treatment of symp-
tomatic fibroids [34].
Uterine myomas are benign growths which originate from The treatment of these conditions is initially conservative
smooth muscle tissue and connective tissue on the walls of and involves the administration of paracetamol or FANS,
the uterus [25]. Their growth is affected by estrogens, growth hydration, and possible antibiotic therapy.
hormones, and progesterone [26]. If this therapy does not solve the problem, surgical
They are the most common benign gynecological pathol- removal of myoma via laparoscopic or laparotomy can be
ogy, with an incidence of between 20 and 77% in premeno- performed.
pausal women, but the real incidence is not known as more
than 50% of these tumors are asymptomatic [27, 28].
Their symptoms can include abnormal bleeding, heavy 33.1.3 Acute Pelvic Inflammatory Disease
menstrual bleeding, pain, a feeling of compression, and uri-
nary symptoms [29, 30]. Pelvic inflammatory disease (PID) is caused by an infection
A bimanual gynecological examination is often used in ascending from the vagina and endocervix, causing endome-
the first instance to verify if the patient has uterine fibroids tritis, salpingitis, parametritis, oophoritis, ovarian tube
[29]. abscesses, and/or pelvic peritonitis [35]. The responsible
Uterine fibroids are often suspected in a premenopausal causal agents are microorganisms that are transmitted sexu-
woman when an enlarged uterus or mass is palpated during a ally, such as Neisseria gonorrhoeae, Chlamydia trachoma-
pelvic examination or when she reports heavy menstrual tis, Mycoplasma genitalium, and other microorganisms that
bleeding [31]. Ultrasonography is the standard confirmatory are present in the vaginal flora (i.e., anaerobic, G. vaginalis,
test because it can easily and inexpensively differentiate a Haemophilus influenzae, E. coli, other enteric gram-negative
fibroid from a pregnant uterus or an adnexal mass [31]. bacteria, Streptococcus agalactiae) [36]. Moreover, cyto-
The need for further imaging depends on the clinical find- megalovirus (CMV), M. hominis, U. urealyticum, and M.
ings in the patient. In women with heavy menstrual bleeding, genitalium could also be associated with some cases of PID,
ultrasonographic examination after the infusion of saline also not transmitted sexually [37–39].
486 A. Ragusa et al.
men), ovarian tube abscess, and impossibility of excluding Meyer suggested another theory regarding metaplasia
emergency surgery. In these cases, parenteral therapy is indi- [56]: endometrium and peritoneum derive from the same
cated [44]. coelomic wall epithelium, which can transform into endome-
Partners of women with PID should undergo screening trial-type glands in response to unknown stimuli; this could
tests for gonorrhea and chlamydia. Abstention from unpro- explain endometriosis in unusual sites and in women who
tected sexual intercourse is recommended until both the part- have undergone total hysterectomy and are not taking estro-
ner and patient have completed the treatment. gen replacement.
Symptoms: the presentation of endometriosis is highly
variable and ranges from debilitating pelvic pain and infertil-
33.1.4 Pelvic Endometriosis ity to no symptoms [57]: pain can include dysmenorrhea,
dyspareunia, and dyschezia, depending on the site involved
Endometriosis can be defined as the presence of endometrial [51, 58]. There is an overlap of symptoms with many condi-
glands and stroma in ectopic locations, primarily the pelvic tions, both gynecological and not.
peritoneum, ovaries, fallopian tubes, vagina, cervix, utero- Sterility is another important consequence of endo-
sacral ligaments, and rectovaginal septum [48] but also in metriosis (20–30% of patients): it can be caused by
extrapelvic sites, i.e., laparotomy scars, pleura, lungs, dia- adherences or by a decreased production of oocytes [59];
phragm, kidneys, spleen, gallbladder, nasal mucosa, spinal periovarian and peritubal adhesions can interfere
canal, stomach, or breast [49]. Ectopic tissues respond to mechanically with ovum transport, peritoneal endome-
normal cyclic hormonal stimulation as they have the same triosis interferes with tubal motility, corpus luteum func-
steroid receptors as normal endometrium. Microscopic inter- tion, and folliculogenesis. Aromatase is believed to raise
nal bleeding, with subsequent inflammatory response, neo- prostaglandin E levels via an increased cyclooxygen-
vascularization, and fibrosis formation is responsible for the ase-2 expression. Endometriosis can also cause a
clinical consequences of this disease [50]. decrease in fertility by binding more sperm to the ampul-
Epidemiology: this condition affects 6–10% of women of lary epithelium and so affecting sperm-endosalpingeal
childbearing age, with a prevalence of 38% in infertile interactions [60].
women and 71–87% of women with chronic pelvic pain Diagnosis: pelvic ultrasonography, MRI, and CT scan-
[51]. The incidence remains stable, although improved rec- ning are usually useful in the case of advanced disease with
ognition may have led to an increased diagnosis rate. endometrial cyst formation or anatomic distortion.
Risk factors include family history, early menarche, short Visualization of endometrial implants is the definitive
menstrual cycles and prolonged flow, heavy bleeding, nulli- method of diagnosis, mainly by laparoscopy.
parity, delayed childbearing, and anatomic alterations [52]. Differential diagnosis can be carried out for appendicitis,
Etiology: the cause of endometriosis is still unclear. diverticulitis, urinary tract infections and cystitis (by urinaly-
Several theories have tried to explain this condition, but none sis and urine culture), chlamydia infections, gonorrhea and
of them have been fully proved [48, 53]. Leading theories pelvic inflammatory disease (by cervical Gram stain and cul-
include metaplastic conversion of coelomic epithelium and tures), ectopic pregnancy, ovarian cyst, and ovarian torsion
hematogenous or lymphatic dispersion of endometrial cells, (by ultrasound).
but it is more likely to be a combination of these [54]. Staging: the American Society for Reproductive Medicine
In 1927, Sampson proposed his theory of retrograde classification of endometriosis is the most widely used stag-
menstruation through the fallopian tubes into the perito- ing system [61] (Figs. 33.2 and 33.3). Point scores are
neal cavity, so causing endometriosis. Later, this was assigned according to the number and size of lesions and
found to be a common physiologic phenomenon that their bilaterality, as well as to the associated adhesion forma-
could not appropriately explain the onset of endometrio- tion. This is a method of recording laparoscopic findings.
sis, although it probably increases the risk of developing This classification does not correlate with pain and other
this condition. symptoms. It can also be used to monitor a patient’s response
More recently, research has focused on the role played by to therapy, although it requires laparoscopic or, less fre-
the immune system in the pathogenesis of endometriosis quently, laparotomic surgery both initially and for
[55]; women with this disorder have increased humoral follow-up.
immune responsiveness and macrophage activation, as well Treatment: as endometriosis depends on a woman’s cyclic
as decreased cell-mediated immunity with diminished T-cell production of menstrual hormones, an improvement in this
and natural killer cell responsiveness. condition can be achieved by suppressing the hormonal
488 A. Ragusa et al.
ENDOMETRIOSIS
Peritoneum
Superficial 1 2 4
Deep 2 4 6
R Superficial 1 2 4
Deep 4 16 20
Ovary
L Superficial 1 2 4
Deep 4 16 20
POSTERIOR CULDESAC Partial Complete
OBLITERATION 4 40
ADHESIONS < 1/3 Enclosure 1/3-2/3 Enclosure > 2/3 Enclosure
R Filmy 1 2 4
Ovary
Dense 4 8 16
L Filmy 1 2 4
Dense 4 8 16
R Filmy 1 2 4
Dense 4 8 16
Tube
L Filmy 1 2 4
Dense 4* 8* 16
*If the fimbriated end of the fallopian tube is completely enclosed, change the point assignment to 16.
Additional Endometriosis: Associated Pathology:
Fig. 33.2 American Society for Reproductive Medicine revised classification of endometriosis, 1985 [61]
rhythm. Gonadotropin-releasing hormone (GnRH) agonists, Surgical management of endometriotic lesions usually
androgens, progestins, and oral contraceptive pills can be provides pain relief and an improvement of symptoms [63],
prescribed for this purpose. Nonsteroidal anti-inflammatory with a non-predictable improvement of pregnancy rates.
agents have not been proven to have any benefit in placebo- With conservative surgery, the aim is to remove visible
controlled trials [62]. endometriotic implants and lyse peritubal and periovarian
33 Updates in the Management of Ob-Gyn Emergencies 489
Fig. 33.3 American Society for Reproductive Medicine revised classification of endometriosis, 1985 [61]
adhesions with a laparoscopic approach. Ablation can be 33.1.5 Severe Vaginal Bleeding
performed with laser or electrodiathermy. These techniques
were shown to be effective for relieving pelvic pain in 87% Severe vaginal bleeding is a condition that may be related to
of patients [64]. many etiologies, both functional and structural. It can take
The indication for semiconservative surgery is mainly for place during menstrual flow, as an increased blood loss, or
women who have no desire for future childbearing, are too between two menstrual flows. These situations are, respec-
young for surgical menopause, and are in strong need of pain tively, called menorrhagia and metrorrhagia.
relief. Such surgery consists of hysterectomy and cytoreduc- Munro in 2011 proposed a classification system for
tion of pelvic endometriosis. abnormal uterine bleeding (AUB) in non-gravid women of
Radical surgery includes total hysterectomy with bilateral reproductive age that was officially approved by FIGO
oophorectomy and cytoreduction of visible endometriosis. [65]. This system is called “PALM-COEIN,” as an acro-
Adhesiolysis is performed to recover mobility and normal nym of the nine categories of causes of vaginal bleeding
intrapelvic relationships. (Fig. 33.4):
490 A. Ragusa et al.
Polyp Coagulopathy important to consider this cause, as it has been proven that
Adenomyosis Ovulatoru dysfuctions coagulation disorders can often be forgotten in differential
Submucosal
Leiomyoma Endometrial diagnosis of vaginal bleeding [70, 71]. These conditions
Other
Malignancy & hyperplasia latrogenic require a hematologic approach and specific treatment.
Not yet classified Coagulopathy can also be caused by medications; this case
would enter the “Iatrogenic” category, but, since women tak-
ing these drugs usually have a hemostasis disorder, it is still
included in the “Coagulopathy” category [65].
Ovulatory dysfunction: this is a common cause of AUB,
generally manifesting as a combination of unpredictable tim-
ing of bleeding and variable amount of flow. Disorders of
ovulation may be present as a variety of menstrual issues,
Fig. 33.4 A simple way to remember the causes of AUB; the first four from amenorrhea, through light and infrequent spotting, to
(PALM) are structural anomalies; the others are not related to structural
anomalies [65] episodes of extremely heavy menstrual bleeding (HMB),
requiring medical or even surgical intervention. Some ovula-
tory disorders have a clear endocrinological etiology, i.e.,
Polyp hypothyroidism, polycystic ovary syndrome, mental stress,
Adenomyosis hyperprolactinemia, anorexia, obesity, weight loss, or
Leiomyoma extreme exercise. In some cases, the disorder can be iatro-
Malignancy and hyperplasia genic, due to gonadal steroids or phenothiazines and tricyclic
Coagulopathy antidepressants [65].
Ovulatory dysfunction Endometrial: if abnormal bleeding takes place in the con-
Endometrial text of regular menstrual bleeding, characteristic of ovula-
Iatrogenic tory cycles, and if no other causes are identified, the cause is
Not yet classified probably a primary disorder of the endometrium. There
could be a deficit in the endometrial production of vasocon-
Polyps: both endometrial and endocervical. These forma- strictors, such as endothelin 1 and prostaglandin F2α, or an
tions have a variable vascular, glandular, fibromuscular, and accelerated lysis of the endometrial clot for augmented lev-
connective tissue; they are usually asymptomatic but can els of plasminogen activator, with an increased concentration
also bleed [66]. Polyps are usually benign, but a small minor- of molecules promoting vasodilation, i.e., prostaglandin E2
ity may have atypical or malignant features [67]. A therapeu- (PGE2) and prostacyclin (PGI2) [72–74]. Unfortunately, it is
tic approach consists of removal, mostly by hysteroscopy. not possible to measure these abnormalities at present. Other
Adenomyosis: the relationship between AUB and adeno- secondarily disorders can cause endometrial bleeding, such
myosis is still unclear; adenomyosis can be assessed with as inflammation or infection of endometrial tissue, problems
MRI and ultrasonography, but as the latter is more available in the uterine phlogistic response and disorders in local vas-
in common practice, it is proposed that ultrasound criteria culogenesis. The role played by inflammation in uterine
comprise the minimum requirements for inclusion in the bleeding is still not clear: a retrospective evaluation of
PALM-COEIN system. women with chronic endometritis could not assess a correla-
Leiomyoma: this is a benign fibromuscular formation of tion between inflammation and AUB [75, 76], but there is
myometrium, also known as fibroid or myoma. There is a data that supports a relationship between AUB and Chlamydia
high prevalence of this benign tumor worldwide, and it is trachomatis infection [77]. An involvement of endometrium
often asymptomatic. Fibroids can be classified according to as a cause of abnormal uterine bleeding should probably be a
their number, size, and location, but the PALM-COEIN sys- diagnosis of exclusion.
tem just includes the categorization of intramural and subse- Iatrogenic: there are several possible iatrogenic causes of
rosal lesions. They are usually removed, with relief of vaginal bleeding, by intrauterine devices, both medicated or
symptoms, if present [68]. not, and a multitude of drugs. Gonadal steroid therapy is very
Malignancy and hyperplasia: atypical hyperplasia and commonly an agent of AUB, which in this case is called
malignancy are quite uncommon but are a significant cause “breakthrough bleeding (BTB).” Systemically administered
of vaginal bleeding that requires further investigation and steroids, such as progestins, estrogens, and androgens, have
classification according to the WHO and FIGO system [69]. a therapeutic effect on the hypothalamic-pituitary-ovarian
Coagulopathy: this term includes the spectrum of sys- axis and directly affect the endometrium itself. These drugs
temic disorders of hemostasis that may cause vaginal bleed- are used as hormonal contraceptives, and bleeding is usually
ing, i.e., von Willebrand disease (VWD). It is particularly due to their periodic withdrawal. BTB is more frequent in
33 Updates in the Management of Ob-Gyn Emergencies 491
with an average duration of about 20 min. Average healing Clinical assessment must be carried out by expert person-
time is 2 weeks or less. Adverse events are generally rare and nel, and, when possible, the victim must have the possibility
are not life-threatening. Regardless of the treatment, recur- to choose the sex of the examiner.
rences occur in less than 20% of patients, with few exceptions Complete assessment in the case of sexual violence
(the highest percentage is for those after aspiration only). includes [93]:
The best treatment has still not been identified, and in existing
literature, the best intervention among those described previ- –– Consent to clinical examination
ously has not been defined. The operator can, therefore, choose –– Remote and recent medical history, including the descrip-
the suitable treatment on the basis of the patient’s characteristics tion of the events, gynecological obstetric history
(symptoms, age, size of abscess, etc.), the resources of the hospi- –– Physical examination
tal where he/she is working, and his/her experience [81]. –– Detailed examination of the genito-anal apparatus
–– Recording and classification of the identified lesions
–– Collection and preservation of biological samples
33.1.7 Sexual Violence –– Forensic report
33.1.7.1 Definition In women, genital trauma is more easily seen behind the
Violence against women is a major public health and human posterior vulvar commeasure, labia minora, hymen, and/or
rights concern. Sexual violence is defined as, “any sexual fossa navicularis (fossa of vestibule of vagina).
act, attempt to obtain a sexual act, unwanted sexual comments The most frequent types of genital trauma include [91]:
or advances, or acts to traffic women’s sexuality, using coer- Lacerations (Fig. 33.5)
cion, threats of harm or physical force, by any person regard-
less of relationship to the victim, in any setting, including but –– Bruising
not limited to home and work” [91]. –– Abrasions
–– Redness and swelling (Fig. 33.6)
33.1.7.2 Prevalence
Studies show that most victims are female, and that the violence The most frequent non-genital traumas include:
is generally committed by a man, and that many victims know
their tormentor [91]. Global statistics show that between 13 and –– Hematomas and bruises
61% of women 15–49 years old report that an intimate partner –– Lacerations
has physically abused them at least once in their lifetime [92].
There is significant under-reporting of sexual violence. The rea-
sons for nonreporting are complex and multifaceted but typi-
cally include fear of retribution or ridicule and a lack of
confidence in investigators, police, and health workers. Sexual
violence has a significant negative impact on the health of popu-
lations. The main consequences are listed in Table 33.1 [91].
Table 33.3 Shows the samples that are more frequently taken in the case of sexual violence [91]
Site Material Equipment Sampling instructions Notes
Anus Semen Cotton swabs and Use swab and slides to collect and plate material; lubricate 1
(rectum) microscope slides instruments with water, not lubricant
Lubricant Cotton swab Dry swab after collection
Blood Drugs Appropriate tube Collect 10 mL of venous blood 2
DNA (victim) Appropriate tube Collect 10 mL of blood
Clothing Adherent foreign Paper bags Clothing should be placed in a paper bag(s). Collect paper sheet 3
materials (e.g. semen, or drop cloth. Wet items should be bagged separately
blood, hair, fibres)
Genitalia Semen Cotton swabs and Use separate swabs and slides to collect and plate material 1
microscope slide collected from the external genitalia, vaginal vault and cervix;
lubricate speculum with water not lubricant or collect a blind
vaginal swab (see Fig. 33.11)
Hair Comparison to hair Sterile container Cut approximately 20 hairs and place hair in sterile container 4
found at scene
Mouth Semen Cotton swabs, sterile Swab multiple sites in mouth with one or more swabs (see 1
container (for oral washings) Fig. 33.12). To obtain a sample of oral washings, rinse mouth
or dental flossing with 10 mL water and collect in sterile container
DNA (victim) Cotton swab 5
Nails Skin, blood, fibres, Sterile toothpick or similar Use the toothpick to collect material from under the nails or the 6
etc. (from assailant) or nail scissors/clippers nail(s) can be cut and the clippings collected in a sterile container
Sanitary Foreign material (e.g. Sterile container Collect if used during or after vaginal or oral penetration 7
pads/ semen, blood, hair)
tampons
Skin Semen Cotton swab Swab sites where semen may be present 1
Saliva (e.g. at sites of Cotton swab Dry swab after collection
kissing, biting or
licking), blood
Foreign material (e.g. Swab or tweezers Place material in sterile container (e.g. envelope, bottle)
vegetation, matted
hair or foreign hairs)
Urine Drugs Sterile container Collect 100 mL of urine 2
494 A. Ragusa et al.
33.2.1.1 Introduction
Antepartum hemorrhages are defined as a blood loss from
the genitals during the second part of the pregnancy and
complicate 2–5% of pregnancies. They can be divided into
placental abruption hemorrhages (40%), placenta previa
(20%), local causes (10%), vasa previa (0.5%), and uncertain
Fig. 33.7 Vaginal swab (With permission of World Health origin (30%) [94].
Organization, Guidelines for medico-legal care of victims of sexual
violence, 2003) 33.2.1.2 Placenta Previa
Placenta abruption is found in 1% of pregnancies, more fre-
quently during young maternal ages [95, 96].
The most predictive risk factor is abruption in a previous
pregnancy. Other risk factors for placental abruption include:
pre-eclampsia, fetal growth restriction, non-vertex presenta-
tions, polyhydramnios, advanced maternal age, multiparity,
low body mass index (BMI), pregnancy following assisted
reproductive techniques, intrauterine infection, premature
rupture of membranes, abdominal trauma (both accidental
and resulting from domestic violence), smoking and drug
misuse (cocaine and amphetamines) during pregnancy. First
trimester bleeding increases the risk of abruption later in the
pregnancy [97].
The clinical picture is characterized on the basis of the
entity of the bleeding at three levels [95, 96]:
tetanic in more serious cases. Nausea e sickness could also intrapartum hemorrhage, hysterectomy, postpartum hemor-
be among the symptoms [98]. rhage, sepsis, and thrombophlebitis. Fetal complications are
A scan used in the diagnosis of placental abruption is not perinatal mortality (4–8%), prematurity, and delayed intra-
a very sensitive technique, even if specific [99]. uterine growth.
Cardiotocography is not always useful in initial phases, but it
becomes increasingly more pathological when the abruption 33.2.1.3 Antepartum Hemorrhage:
involves at least half of the placental bed. The most frequent Management
changes are severe variable decelerations, late decelerations, All patients with blood loss after 20 weeks must be trans-
bradycardia and the reduction in variability [100]. ported to the delivery room. The two primary objectives are
Placental abruption involves a high level of perinatal the hemodynamic evaluation of the mother and the assess-
mortality and morbidity and can cause rare, but serious ment of the well-being of the fetus. Two large venous
maternal and fetal complications [95, 96]. Maternal compli- accesses must be put in place for hematocrit and blood typ-
cations include: mortality (1%), hypovolemic shock (5%), ing sampling. The clinical situation can differ according to
acute renal failure (0.5–1.5%), disseminated intravascular whether or not there is a state of shock. Once the patient has
coagulation (CID) (10%), postpartum hemorrhages (25%) been stabilized and fetal conditions assessed, the cause of the
and recurrence (8–25%). bleeding must be investigated. The clinical situation depends
Placenta previa is a condition in which the placenta is on the extent of the blood loss, on the period of the preg-
positioned in the lower uterine segment and can reach or nancy during which it takes place, and on the degree of
cover, partially or completely, the internal uterine orifice. maternal-fetal compromise.
There is an incidence of 0.3% in single pregnancies [94]. On
the basis of the topography, four possible eventualities can
be highlighted: 33.2.2 Postpartum Hemorrhage
Intervention should be made in the “golden hour” to • Thrombin (in relation to blood coagulation disorders due
increase the chances of survival of the patient [104, 107]. to thrombin dysfunction; any coagulation defects should
be evaluated and corrected with ROTEM/TEG monitor-
33.2.2.2 Medical Management of PPH ing, if available).
The first action to be taken in the case of PPH is to request
the cooperation of other medical and paramedic staff. While The restoration of the circulating volume by giving the
waiting for support, an assessment of the extent of the bleed- least volume of crystalloids (Ringer-lactate/acetate as the
ing through retroplacental bag, gauze, and drapes is advised first line) or colloids [115] until the hypoperfusion is cor-
[108, 109]. rected, based on an evaluation of the clinical and laboratory
Simultaneous with the assessment of blood loss is the variables (sensory state, diuresis, lactates, and deficit base),
need to begin the monitoring of vital signs: blood pressure, and speeding up the request of blood products should be car-
respiratory rate, heart rate, electrocardiography (ECG), pulse ried out only when resolution of the effective hemorrhage is
oximetry, temperature, and diuresis through a urinary cathe- not achieved.
ter. Checking should be carried out initially every 10 min, During massive hemorrhage, fibrinogen is one of the first
according to the clinical evolution, and then every 30 min coagulation factors to decrease beyond critical levels. Several
[108]. At this stage, a request for blood components should recent studies have suggested that fibrinogen is an important
be sent to the transfusion center. predictor of severe PPH [116, 117]. Some guidelines have
Two large venous access points (16 G or, better, 14 G) indicated that fibrinogen concentrate should be the replace-
should also be established; the use of infusion pumps is pref- ment therapy of choice [118].
erable. A urinary catheter also needs to be inserted to empty Transfusion in the presence of the effective PPH is carried
the bladder. out based on clinical indications and not on information
The pharmacologic therapy at this stage includes oxyto- obtained from blood chemistry tests.
cin and tranexamic acid (TXA). There is significant variation Cases that do not respond to the therapies described above
in practice in this regard. However, oxytocin together with require a conservative surgical interventionist approach. In
TXA is to be the first choice (20 IU in 500 mL saline in 2 h) case of non-response to the measures outlined thus far, the
[105]. If no effect is observed after 20 min, a second-line application of partial or total hysterectomy will be
uterotonic may have to be given. necessary.
Evidence supporting the early use of TXA in massive
hemorrhage, at variable dosage of between 1 and 4 g [108– 33.2.2.3 Surgical Management of PPH
113], has been increasing rapidly. Once the peritoneum has been opened, the integrity of the
At the same time, samples regarding blood group have to womb must be checked, carefully examining the uterine
be taken, and repeated blood counts and basic coagulation walls and aiming at obtaining a contraction of the womb uti-
tests should be carried out: prothrombin time, partial throm- lizing a prolonged massage [119]. If this massage has no
boplastin time, fibrinogen, and antithrombin. result, a compressive type of intervention must be carried out
Close monitoring is needed to avoid or correct hypother- (B-Lynch or Hayman technique) which solves the problem
mia and to measure and avoid acidosis (lactates >2 mmol/L) in more than 85% of cases [120–126].
and desaturation. We suggest that an arterial blood gas In the rare cases that B-Lynch or Hayman techniques are
analysis be carried out to obtain a baseline hemoglobin not effective, it is necessary to proceed without further delay
level. with a hysterectomy.
The source of bleeding should be established by applying
the rule of the 4 Ts [106], and the relevant corrective actions B-Lynch
should be determined: The B-Lynch technique is simple to carry out and has excel-
lent results if the indication is correct. In order to carry out
• Tone (bimanual uterine compression, intracavitary uter- the intervention after a vaginal birth, in the absence of hys-
ine tamponade through a hydrostatic balloon catheter, and terotomy, as in the case of a cesarean section, the prevesical
use of uterotonics). In the absence of a hydrostatic bal- peritoneum must be opened, opening the uterine bladder
loon, a latex glove or a condom can be used with good fold of peritoneum and detaching the bladder downward at
results, as suggested by the FIGO 2012 Guidelines [114]. least 2 cm. The lower uterine segment must be cut diago-
It should be emphasized that the use of gauze tamponade nally for 4 cm. The uterus must be exteriorized from the
is now discouraged. laparotomic breach, proceeding using a monofilament
• Tissue (exploration and evacuation of the uterus). thread of at least 120 cm in length with a rounded needle of
• Trauma (vaginal lacerations and cervix and/or uterine more than 48 mm. The anterior part of the uterus is punc-
rupture repair). tured completely on the right side from the dissection of the
33 Updates in the Management of Ob-Gyn Emergencies 497
Hayman
This case also involves the creation of handles, from 2 to 4,
which, unlike the B-Lynch, are not connected to each other.
First of all, we proceed, as for B-Lynch, with the detachment
of the bladder. Two stitches are then placed on the lower uter-
ine segment, next to each other, taking care to leave a space
for secretion (Fig. 33.10).
The numerous anastomoses between uterine artery, lower 33.2.3 Inversion of the Uterus
bladder, and long vaginal bowels are dramatically reduced,
obtaining a net decrease in the vascularization of the lower Uterine inversion is a rare complication of childbirth and hap-
segment, of the cervix and the upper third of the vagina. The pens when the fundus of the uterus descends abnormally through
risks connected to the closure of the hypogastric artery are the genital tract, thus turning itself inside out [128–132].
gluteal necrosis (if the artery is clamped before the first emi- Four grades of uterine inversion are described (Fig. 33.11):
nence of the rear trunk), ureter injury, and more bleeding in
isolation maneuvers. • Grade 1: fundus inverts down to the cervical canal.
• Grade 2: fundus inverts into the vagina.
Hysterectomy • Grade 3: fundus is visible at the introitus.
Subtotal hysterectomy has lower surgical morbidity and is • Grade 4: complete inversion of both the uterus and vagina.
the operation of choice, unless there is trauma to the cervix Reported incidence ranges from 1/2000 to 1/6400 [128–
or lower segment. 132]. Maternal mortality can be high as 15% if the condi-
If the cervix and paracolpos are not involved as the tion is not promptly diagnosed and corrected. Factors that
source of hemorrhage, subtotal hysterectomy should be ade- have been associated with this condition are summarized
quate to achieve hemostasis, which is the objective of the in (Table 33.4).
intervention. Additionally, the procedure is safer, faster,
easier to carry out, and less likely to cause damage to the
bladder or ureters compared with total hysterectomy [103, 33.2.3.1 Diagnosis
127]. However, if the lower segment and paracolpos are Uterine inversion can be difficult to diagnose, particularly if
involved in the hemorrhage, such as in cases of placenta pre- the fundus is not outside the introitus.
via, total hysterectomy will be necessary for hemostasis Early recognition is important to enable prompt treatment
[103, 127]. and to reduce morbidity and mortality [128–132].
Grade 1 Grade 2
A
A
Grade 3 Grade 4
33 Updates in the Management of Ob-Gyn Emergencies 499
1. When the presenting part does not adequately fill the pel-
vis because of maternal or fetal characteristics
2. When obstetric interventions are performed that dislodge
the presenting part are performed
33.2.4.1 Diagnosis
Early diagnosis is important. A cord prolapsed may be obvi-
ous when there is a loop of cord protruding through the
vulva. However, a prolapsed cord is not always apparent and
may only be found on vaginal examination. It can be sus-
pected when there is an abnormal fetal heart rate pattern in
Fig. 33.13 Surgical correction of uterine inversion with Huntington’s the presence of ruptured membranes, particularly if CTG
method (With permission of Piccin Editore. From Ragusa A, Crescini changes start soon after the rupture [136–142]. In 41–67% of
C. URGENZE ED EMERGENZE IN SALA PARTO, Padova 2015. Casa
Editrice PICCIN Nuova Libreria)
cases, it is associated with severe, sudden decelerations,
often with prolonged bradycardia, or recurrent moderate to
severe variable decelerations.
vessels) to aid replacement of the uterus (Haultain’s tech-
nique). Hysterotomy site is then repaired. 33.2.4.2 Management
• Antibiotics should be given. The approach if the baby is alive and of viable gestation is
• The patients should be monitored closely since re-inver- elevation of the presenting part to relieve compression of the
sion of the uterus is frequent. cord and expedite delivery, usually by cesarean section [145].
Prompt delivery has been shown to improve outcomes.
Cord prolapse is defined as the descent of a loop of umbilical Table 33.5 Risk factors for cord prolapse
cord below the presenting part, in the presence of ruptured Breech presentation
membranes [136–142]. Multiparity
It is an obstetrical emergency and occurs approximately Unstable lie
in 0.1–0.6% of all births, while in breech presentations, its Oblique or transverse lie
incidence can be as high as 1% [136–142]. Polyhydramnios
In cord prolapse, perinatal mortality is due to asphyxia Prematurity
Multiple pregnancy
and is caused by mechanical compression of the cord
Long cord
between the presented part and bony pelvis or by spasm of Low birth weight (<2500 g)
the cord vessels when exposed to cold or manipulations Amniotomy (especially with a high presenting part)
[144, 143]. Sudden rupture of membranes (especially in polyhydramnios)
The interval between diagnosis and birth is significantly Internal podalic version
related to stillbirth and perinatal death [145]. Second twin
33 Updates in the Management of Ob-Gyn Emergencies 501
–– Call for senior help, including an anesthetist, the theater tive birth are met, ventouse or forceps can be
team, and the neonatal team. considered.
–– Site a wide-bore intravenous cannula and take blood for
group and save and full blood count. Regional anesthesia is possible if fetal conditions permit,
–– Administer intravenous fluids. and the safest method of anesthesia for both the mother and
–– Check vitality of the fetus by ultrasound to visualize fetal fetus should be considered.
movements even with the absence of cord pulsation and Team training exercises have been shown to shorten the
inaudible fetal heart tones. interval between diagnosis and delivery and may lead to
–– Relieve cord compression by elevating the presenting improved neonatal outcomes [146–148].
part. This can be achieved by:
Digital elevation of the presenting part of the fetus above
the pelvic inlet: two fingers or the entire hand should 33.2.5 Acute Abdominal Pain During
be kept in the vagina until the baby is born. Pregnancy
Maternal positioning: such as knee-chest facedown posi-
tion or the exaggerate Sims’ position (left lateral with 33.2.5.1 Introduction
a pillow under the left hip) (Fig. 33.14). Acute abdominal pain during pregnancy has an impact that
ranges from 1:500 to 1:635, and 0.2–1% of these patients
If the cord has prolapsed out from the vagina, an attempt require surgery [149].
to gently replace it back with minimal handling is possible. Table 33.6 shows the possible pathologies in relation to
There is no sufficient evidence to recommend the practice of the seat of the pain.
covering the cord with gauzes soaked in warm saline.
Excessive manipulations of the cord should be avoided. 33.2.5.2 Acute Appendicitis
The insidence of acute appendicitis during pregnancy is 1
–– Continuous electronic fetal monitoring should be per- case every 1500–2000 pregnancies and is the cause of 25%
formed, if possible. of surgery for non-obstetric indications [149, 150].
If the cervix is not fully dilated, a cesarean section should
be performed [145]. Diagnosis
If the cervix is fully dilated and the obstetrician The most common symptom is the pain in the lower right
believes that a vaginal delivery can be performed more quadrant (McBurney point). Associated symptoms include
rapidly than a cesarean section, it is appropriate to pro- anorexia, nausea, and sickness. A perforated appendix should
ceed with vaginal delivery. If prerequisites for opera- be suspected if the pain changes from localized to wide-
a b
Fig. 33.14 Maternal positioning to relieve cord compression: (a) knee-chest facedown position; (b) exaggerate Sims’ position (left lateral with a
pillow under the left hip (With permission of Piccin Editore. From Ragusa A, Crescini C. URGENZE ED EMERGENZE IN SALA PARTO, Padova
2015. Casa Editrice PICCIN Nuova Libreria)
502 A. Ragusa et al.
spread. A retrocecal appendix can cause symptoms at the carried out where pain is felt most [152, 153]. Care must be
back or side of the patient [150, 151]. taken to avoid excessive uterine traction, thus avoiding irrita-
On physical examination a Rovsing sign may be noted tion to the uterine bowels, with consequent onset of contrac-
[150, 151]. Stiffness and abdominal defense, irritation of the tions. If the appendix is ruptured or there is evidence of
psoas, and rectal and pelvic pain may not be present. peritonitis, a copious intra-abdominal irrigation should be
Leukocytosis is of little use. However, the predominant neu- carried out. The positioning of drainage can be taken into
trophilia (>80%) and an increase in the C-reactive protein consideration to drain the possible abscess. The patient must
may be of help. A scan can identify an inflamed appendix or be administered perioperative antibiotic therapy with sec-
a periappendiceal abscess. The scan should be performed ond-generation cephalosporins, broad-spectrum penicillins,
with the patient in left lateral decubitus position. An abnor- and carbapenems, together with clindamycin or metronida-
mal appendix has a tubular structure, non-compressible, zole [149–153].
showing no peristalsis, with a diameter of more than 6 mm,
which originates from the base of the cecum [150]. 33.2.5.3 Acute Cholecystitis
If the scan is not decisive and diagnostic doubts persist, it Gallbladder pathologies have an incidence that ranges
indicates a magnetic resonance (MR) should be carried out from 1:1600 to 1:10,000 pregnancies and are thus the sec-
[150]. A computed tomography (CT) must be used if there ond most common cause of non-obstetric surgical prob-
are still diagnostic doubts [149, 150]. lems [150, 151]. Ninety percent of the cases are caused by
an obstruction of the cystic duct by biliary stones or sand
Management [150, 151].
Surgical intervention should be carried out immediately
[152, 153]. Active labor is the only indication to postpone Diagnosis
surgery, which will have to be carried out postpartum [152, The symptoms of acute cholecystitis include nausea, sick-
153]. There are no indications to perform a cesarean section, ness, anorexia, intolerance to fatty foods, dyspepsia, and
except in the case of perforated appendix. Surgery may be mesogastric pain in the upper right quadrant, expanding to
carried out via laparoscopy or laparotomy [152, 153]. In the the top of the scapula. The Murphy sign is rare [150, 151].
case of laparotomy performed during the first trimester, the In more serious cases, the patient may have slight jaundice
incision of the skin must be carried out at the McBurney and signs of sepsis [150, 151]. Lab tests can show an
point [141, 153]. The incision may also be longitudinal, increase in direct bilirubin, transaminase, and bilirubin lev-
paramedian or median [152, 153]. The incision can also be els [150, 151].
33 Updates in the Management of Ob-Gyn Emergencies 503
A scan enables to identify the presence of biliary stones in performing the colonoscopy, surgery is recommended in any
95–98% of cases. Moreover, it is also able to highlight signs of case after delivery due to the high risk (>50%) of recurrences
acute cholecystitis among which edema of the gallbladder with [149, 150, 153].
an increase in wall thickness of more than increase 3 mm, accu-
mulation of peri-cholecystic fluid, biliary stone, and Murphy
sign showing in the scan [149, 154]. Magnetic resonance chol- 33.2.6 Abdominal Trauma During Pregnancy
angiopancreatography (MRCP) can also be used to confirm the
suspicion of biliary stones. Endoscopic retrograde cholangio- 33.2.6.1 Introduction
pancreatography (ERCP) can be used for diagnostic purposes Abdominal trauma during pregnancy is one of the main
or to perform a sphincterotomy to solve possible pancreatitis, causes of maternal death [1]. Most of these traumas are
with minimum exposure to ionizing radiation [149, 154]. caused by domestic violence [155]. Penetrating injuries and
those caused by falling make up the main causes of trauma
Management during pregnancy [156]. The management of traumas during
Symptomatic cholelithiasis is often managed initially pregnancy requires a multidisciplinary approach which
using conservative treatment by means of hydration to involves a trauma surgeon, a specialist in emergency medi-
correct electrolyte, analgesic, anti-inflammatory, and cine, an obstetrician, and a neonatologist [157].
bowel disorders. If there is no improvement after 12–24 h, The management protocol for traumas with regard to a
or there are systemic symptoms, antibiotic treatment must pregnant woman is the same as that for women who are not
be started with third-generation cephalosporins in combi- pregnant. First and foremost, the airways must be managed,
nation with metronidazole. If the conservative treatment bearing in mind that possible intubation could be difficult in
does not result in any improvement, cholecystectomy sur- pregnant women due to the increase in weight and swelling,
gery is indicated via laparoscopic approach. This method characteristic of pregnancy [158]. If the airways are not safe,
can be used in all phases of pregnancy and has been a nasogastric tube should be put in place [159, 160]. The
proven to be safe and well tolerated [154]. patient must be positioned on her left side to increase the
flow of blood to the heart [161, 162].
33.2.5.4 Intestinal Obstruction Priority must be given to the mother’s health over that of
Intestinal obstruction complicates 1 out of 3000 pregnancies the fetus. The patient must be transported to an area with a
and is the third most common cause of for non-obstetric sur- delivery room if her injuries do not endanger the health of
gical problems. Failure to diagnose an intestinal obstruction the mother and if the fetus is ≥23 weeks. If the trauma is
is connected to 6% maternal mortality and 25–40% of fetal severe, or if the fetus is less than 23 weeks, the patient must
death [150, 153]. be managed exclusively by the emergency division [157].
Nevertheless, investigations should never be delayed. Table 33.7 Risk factors for ectopic pregnancy
Computerized tomography (CT) of the abdomen during the Degree of Odds
third 3-month period causes an absorption of radiation of risk Risk factors ratio
3.5 rad, which is below the limit that could cause fetal dam- High Previous ectopic pregnancy 9.3–4.7
Previous tubal surgery 6.0–11.5
age [166]. The use of gadolinium as a contrast medium is not
Tubal ligation 3.0–13.9
toxic to the fetus and can be used when indicated [167]. Tubal pathology 3.5–25
Lab tests such as complete blood count and coagulation, In utero DES exposure 2.4–13
with particular attention to fibrinogen, should be requested. Current IUD use 1.1–45
In pregnant women, the levels of fibrinogen are higher (circa Moderate Infertility 1.1–28
4 g/L). Levels are below 2 g/L could be a sign of DIC. Previous cervicitis (gonorrhea, 2.8–3.7
A FAST scan is useful in the case of abdominal trauma to chlamydia)
History of pelvic inflammatory disease 2.1–3.0
highlight the presence of fluid in the abdomen, and its pres-
Multiple sexual partners 1.4–4.8
ence is an indication to carry out an abdominal CT. Smoking 2.3–3.9
In pregnancies of more than 23 weeks, the well-being of Low Previous pelvic/abdominal surgery 0.93–3.8
the fetus should be assessed by means of monitoring the fetal Vaginal douching 1.1–3.1
heartbeat [157]. Early age of intercourse (<18 years) 1.1–2.5
In the case in which a separation of the placenta is sus-
pected, fetal monitoring for at least 24 consecutive hours is
advisable [157].
Possible complications of traumas during pregnancy are
feto-maternal hemorrhage, rupture of the uterus, and preterm
delivery [157].
33.2.7.1 Definition
Ectopic pregnancies are defined as the implantation of blas-
tocyst embryos outside the uterus [168].
33.2.7.2 Epidemiology
The frequency of ectopic pregnancies has increased as a con-
sequence of the increase in risk factors, and thanks to
improved diagnostics, reaching 2% of all pregnancies in the
USA and 1.4% in Italy [168].
In subpopulations at risk, the incidence is 3% in pregnan-
cies with medically assisted procreation and 10% in patients Fig. 33.15 Hyperechoic ring in ectopic pregnancy
with previous ectopic pregnancies.
Ten percent of patients who go to the A&E department 33.2.7.4 Diagnosis
during the first trimester because of bleeding and/or pelvic
pain will be diagnosed with ectopic pregnancy. Transvaginal Scan
Ectopic pregnancy is still the cause of 4–10% of all mater- Ten percent of direct evidence of extrauterine implants (ges-
nal deaths (hemoperitoneum). tational vitreous sac with or without embryo); more fre-
Table 33.7 shows the risk factors for ectopic pregnancy. quently indirect ultrasound signs, empty uterus (lack of
implant endothelium); free liquid in Douglas; and adnexal
33.2.7.3 Clinical hyperechoic ring (Fig. 33.15: “bagel sign”) [168].
Classical clinical presentation (45% of cases): At endometrial level, not tonic, irregular, without the dou-
ble ring, and absence of embryonic echoes [168].
–– Abdominal pain (97%)
–– Vaginal blood loss (79%) Significance of Chorionic Gonadotropin Beta Values
–– Palpable adnexal mass and/or backward mass that fills the (β-hCG)
Douglas (30%), in women with amenorrhea/positive When the scan is not definite, the differential diagnosis is
pregnancy test between early endothelial pregnancy, premature abortion at
33 Updates in the Management of Ob-Gyn Emergencies 505
an unknown seat, ectopic pregnancy, and vesicular mole: pri- Table 33.8 Precautions to be taken in the case of MTX therapy
mary determinant is the serum dosage of β-hCG [169, 170]. Caveats for physicians and patients regarding the use of methotrexate
(MTX)
–– Early intrauterine pregnancy in regular evolution: in Avoid intercourse until hCG is undetectable
Avoid pelvic exams and ultrasound during surveillance of MTX
48/72 h the level doubles, in ectopic pregnancy this therapy
increase is less, and in vesicular mole the levels are usu- Avoid sun exposure to limit risk of MTX dermatitis
ally much higher. Avoid foods and vitamins containing folic acid
–– Discriminatory area: 2000 UI/L is generally the level Avoid gas-forming foods because they produce pain
above of which, if the pregnancy in the uterus and single, Avoid new conception until hCG is undetectable
the gestational bag with transvaginal probe is shown ASRM Practice Committee. Treatment of ectopic pregnancy. Fertil
(6500 should be seen in transabdominal, while the levels Steril 2008
have not been defined for twin pregnancies yet).
Table 33.9 Treatment and side effects connected to MTX
Effects of the treatment
33.2.7.5 Management Increase in abdominal circumference
Increase in hCG at the beginning of the treatment
–– Waiting conduct (18–33% GEU spontaneous resolution) Vaginal bleeding or spotting
does not affect following fertility [168, 171]. Abdominal pain
–– Criteria: asymptomatic patient, first dosage of Side effects
Epigastric discomfort (heartburn), nausea and sickness
βHCG < 1000 UI/L, with following dosage at 48–72 h with a
Stomatitis
decrease of >15%, paraovarian mass <4 cm, endopelvic dis- Dizziness
charge <100 mL, stability or slow resolution to subsequent Severe neutropenia (rare)
ultrasound checks, and patient’s compliance [168, 171]. Reversible alopecia (rare)
–– Medical therapy (about 50% success) Pulmonary infections (rare)
–– Criteria: symptomatic patient, first dosage of hCG > 1000 UI/L ASRM Practice Committee. Treatment of ectopic pregnancy. Fertil
and <3000 UI/L (3000–5000: risk of failure 5×) even if the Steril 2008
subsequent dosage is stable or reduced, first dosage of
hCG < 1000 UI/L but subsequent dosage at 48–72 h stable/ homolateral ectopic pregnancy, and uncontrolled hemostasis
decreasing <15%/ increase, paraovarian mass <4 cm, BCF [168, 171].
absent, endopelvic discharge <100 mL + stability, or slow If documented trophoblastic peritoneal implants and
resolution to subsequent ultrasound checks [168, 171]. decrease <50% in hCG during the first day compared to pre-
surgery, administration of MTX 50 mgm2 IM single dose
A single dose of methotrexate (MTX) of 50 mg/m2 via [168, 171].
intramuscular injection, followed by weekly monitoring of Perform anti-D immunoprophylaxis in the case of
the hCG and clinical conditions: good response if the Rh-negative blood group.
decrease is >15% between days 4 and 7. If medical therapy Weekly monitoring of βHCG and clinical conditions are
fails (14%): possible new medical therapy, programmed or suggested; serial ultrasound examinations are not useful but
emergency surgery. Table 33.8 shows some precautions to only at hormonal reset and at 4 months from the resetting.
bear in mind during MTX therapy [168, 171]. Avoid possible pregnancies for 6 months from the hormonal
Table 33.9 shows the effects of the treatment and side reset [168, 171].
effects when using MTX.
In conclusion, consultation with an obstetrician/gynecol- hemorrhage or those who are hemodynamically unstable
ogist is indicated for all patients with a diagnosis of sponta- need immediate consultation and treatment.
neous or incomplete abortions. Patients with severe
Fig. 33.16 Case scenario: adnexal torsion. The ovary is enlarged; the stroma is heterogeneous. Medial to the ovary is visible the swollen
salpinx
508 A. Ragusa et al.
Acknowledgments We would like to thank Dr. Marta Betti and Dr. 23. Teng SW, Tseng JY, Chang CK, et al. Comparison of laparoscopy
Anna Carli for the collaboration offered in the drafting of this and laparotomy in managing hemodynamically stable patients
chapter. with ruptured corpus luteum with hemoperitoneum. J Am Assoc
Gynecol Laparosc. 2003;10:474.
24. Reif P, Schöll W, Klaritsch P, Lang U. Rupture of endometriotic
ovarian cyst causes acute hemoperitoneum in twin pregnancy.
Fertil Steril. 2011;95:2125.e1.
References 25. Viswanathan M, Hartmann K, McKoy N, Stuart G, Rankins N,
Thieda P, Lux LJ, Lohr KN. Management of uterine fibroids:
1. McWilliams GD, Hill MJ, Dietrich CS III. Gynecologic emergen- an update of the evidence. Evid Rep Technol Assess (Full Rep).
cies. Surg Clin North Am. 2008;88:265. 2007;(154):1–122.
2. Schrager J, Robles G, Platz T. Isolated fallopian tube torsion: a 26. Evans P, Brunsell S. Uterine fibroid tumors: diagnosis and treat-
rare entity in a premenarcheal female. Am Surg. 2012;78:118. ment. Am Fam Physician. 2007;75(10):1503–8.
3. Bouguizane S, Bibi H, Farhat Y, et al. [Adnexal torsion: a report of 27. Vollenhoven B. Introduction: the epidemiology of uterine leio-
135 cases]. J Gynecol Obstet Biol Reprod (Paris). 2003;32:535. myomas. Baillieres Clin Obstet Gynaecol. 1998;12(2):169–76.
4. Varras M, Tsikini A, Polyzos D, et al. Uterine adnexal torsion: 28. Greenberg MD, Kazamel TI. Medical and socioeconomic
pathologic and grayscale ultrasonographic findings. Clin Exp impact of uterine fibroids. Obstet Gynecol Clin North Am.
Obstet Gynecol. 2004;31:34. 1995;22(4):625–36.
5. Houry D, Abbott JT. Ovarian torsion: a fifteen year review. Ann 29. Tropeano G, Amoroso S, Scambia G. Non-surgical management
Emerg Med. 2001;38:156. of uterine fibroids. Hum Reprod Update. 2008;14(3):259–74.
6. White M, Stella J. Ovarian torsion: 10 year perspective. Emerg 30. Downes E, Sikirica V, Gilabert-Estelles J, Bolge SC, Dodd
Med Australas. 2005;17:231. SL, Maroulis C, et al. The burden of uterine fibroids in five
7. Oltmann SC, Fischer A, Barber R, et al. Cannot exclude torsion European countries. Eur J Obstet Gynecol Reprod Biol.
a - 15year review. J Pediatr Surg. 2009;44:1212. 2010;152(1):96–102.
8. Tsafrir Z, Hasson J, Levin I, et al. Adnexal torsion: cystectomy 31. Stewart EA. Clinical practice. Uterine fibroids. N Engl J Med.
and ovarian fixation are equally important in preventing recur- 2015;372(17):1646–55.
rence. Eur J Obstet Gynecol Reprod Biol. 2012;162:203. 32. Munro MG, Critchley HO, Fraser IS. The FIGO classification of
9. Kokoska ER, Keller MS, Weber TR. Acute ovarian torsion in chil- causes of abnormal uterine bleeding in the reproductive years.
dren. Am J Surg. 2000;180:462. Fertil Steril. 2011;95(7):2204–8.
10. Rousseau V, Massicot R, Darwish AA, et al. Emergency manage- 33. Ouyang DW, Economy KE, Norwitz ER. Obstetric complica-
ment and conservative surgery of ovarian torsion in children: a tions of fibroids. Obstet Gynecol Clin North Am. 2006;33(1):
report of 40 cases. J Pediatr Adolesc Gynecol. 2008;21:201. 153–69.
11. Anthony EY, Caserta MP, Singh J, Chen MY. Adnexal masses in 34. Pérez-López FR, Ornat L, Ceausu I, Depypere H, Erel CT,
female pediatric patients. AJR Am J Roentgenol. 2012;198:W426. Lambrinoudaki I, et al. EMAS position statement: management of
12. Wilkinson C, Sanderson A. Adnexal torsion a multimodality uterine fibroids. Maturitas. 2014;79(1):106–16.
imaging review. Clin Radiol. 2012;67:476. 35. Wiesenfeld HC, Sweet RL, Ness RB, et al. Comparison of acute
13. Valsky DV, EshBroder E, Cohen SM, et al. Added value of the and subclinical pelvic inflammatory disease. Sex Transm Dis.
grayscale whirlpool sign in the diagnosis of adnexal torsion. 2005;32:400–5.
Ultrasound Obstet Gynecol. 2010;36:630. 36. Ness RB, Kip KE, Hillier SL, et al. A cluster analysis of bacterial
14. Vijayaraghavan SB, Senthil S. Isolated torsion of the fallo- vaginosis-associated microflora and pelvic inflammatory disease.
pian tube: the sonographic whirlpool sign. J Ultrasound Med. Am J Epidemiol. 2005;162:585–90.
2009;28:657. 37. Cohen CR, Mugo NR, Astete SG, et al. Detection of Mycoplasma
15. Albayram F, Hamper UM. Ovarian and adnexal torsion: spectrum genitalium in women with laparoscopically diagnosed acute sal-
of sonographic findings with pathologic correlation. J Ultrasound pingitis. Sex Transm Infect. 2005;81:463–6.
Med. 2001;20:1083. 38. Haggerty CL, Totten PA, Astete SG, et al. Mycoplasma geni-
16. BenAmi M, Perlitz Y, Haddad S. The effectiveness of spectral and talium among women with nongonococcal, nonchlamydial
color Doppler in predicting ovarian torsion. A prospective study. pelvic inflammatory disease. Infect Dis Obstet Gynecol.
Eur J Obstet Gynecol Reprod Biol. 2002;104:64. 2006;2006:30184.
17. Lee EJ, Kwon HC, Joo HJ, et al. Diagnosis of ovarian torsion with 39. Jurstrand M, Jensen JS, Magnuson A, et al. A serological study of
color Doppler sonography: depiction of twisted vascular pedicle. the role of Mycoplasma genitalium in pelvic inflammatory disease
J Ultrasound Med. 1998;17:83. and ectopic pregnancy. Sex Transm Infect. 2007;83:319–23.
18. Taskin O, Birincioglu M, Aydin A, et al. The effects of twisted 40. Ross J, Judlin P, Jensen J, International Union Against Sexually
ischaemic adnexa managed by detorsion on ovarian viability and Transmitted Infections. 2012 European guideline for the man-
histology: an ischaemic are perfusion rodent model. Hum Reprod. agement of pelvic inflammatory disease. Int J STD AIDS.
1998;13:2823. 2014;25(1):1–7. https://doi.org/10.1177/0956462413498714..
19. Jones HW, Jones GS. Novak textbook of gynecology. 10th ed. Epub 29 Aug 2013
Baltimore: Wolters Kluwer Lippincott Williams & Wilkins; 1981. 41. Government of Western Australia. Department of Health Benign
p. 471. gynaecology acute pelvic inflammatory disease. Clinical guide-
20. Mathevet P, Nessah K, Dargent D, Mellier G. Laparoscopic man- lines gynaecology 2015.
agement of adnexal masses in pregnancy: a case series. Eur J 42. European Guideline for the Management of Pelvic Inflammatory
Obstet Gynecol Reprod Biol. 2003;108:217. Disease UK National Guideline for the Management of Pelvic
21. Bottomley C, Bourne T. Diagnosis and management of ovarian Inflammatory Disease 2011.
cyst accidents. Best Pract Res Clin Obstet Gynaecol. 2009;23:711. 43. UK National Guideline for the Management of Pelvic
22. Kim JH, Lee SM, Lee JH, et al. Successful conservative manage- Inflammatory Disease 2011.
ment of ruptured ovarian cysts with hemoperitoneum in healthy 44. CDC-Center for Disease Control and Prevention. Sexually trans-
women. PLoS One. 2014;9:e91171. mitted disease treatment guidelines 2015.
33 Updates in the Management of Ob-Gyn Emergencies 509
45. Workowski KA. Centers for Disease Control and Prevention sexu- bleeding: results regarding the degree of intramural extension.
ally transmitted diseases treatment guidelines. Clin Infect Dis. Obstet Gynecol. 1993;82(5):736–40.
2015;61(Suppl 8):S759–62. https://doi.org/10.1093/cid/civ771. 69. Tavassoli FA, Devilee P. World Health Organization classification
46. Maleckiene L, et al. Comparison of clinical and laparoscopic of tumors: pathology and genetics of tumours of the breast and
diagnoses of pelvic inflammatory disease. Int J Gynaecol Obstet. female genital organs. Lyon: IARC Press; 2003.
2009;104(1):74–17. 70. Dilley A, Drews C, Lally C, Austin H, Barnhart E, Evatt B. A
47. Ness RB, Trautmann G, Richter HE, et al. Effectiveness of treat- survey of gynecologists concerning menorrhagia: perceptions of
ment strategies of some women with pelvic inflammatory disease: bleeding disorders as a possible cause. J Womens Health Gend
a randomized trial. Obstet Gynecol. 2005;106(3):573–80. Based Med. 2002;11(1):39–44.
48. Burney RO, Giudice LC. Pathogenesis and pathophysiology of 71. Byams VR, Anderson BL, Grant AM, Atrash H, Schulkin
endometriosis. Fertil Steril. 2012;98(3):511–9. J. Evaluation of bleeding disorders in women with menorrhagia:
49. Jubanyik KJ, Comite F. Extrapelvic endometriosis. Obstet a survey of obstetrician-gynecologists. Am J Obstet Gynecol.
Gynecol Clin North Am. 1997;24(2):411–40. 2012;207(4):269.e1–5.
50. Avraham S, Seidman DS. Surgery versus pharmacological treat- 72. Gleeson NC. Cyclic changes in endometrial tissue plasminogen
ment for endometriosis. Future Med. 2014;10:161–6. activator and plasminogen activator inhibitor type 1 in women
51. American College of Obstetricians and Gynecologists. Practice with normal menstruation and essential menorrhagia. Am J Obstet
Bulletin 114. Management of Endometriosis. Obstet Gynecol. Gynecol. 1994;171(1):178–83.
2010;116(1):223–36. 73. Smith SK, Abel MH, Kelly RW, Baird DT. Prostaglandin synthe-
52. Viganò P, Parazzini F, Somigliana E, Vercellini P. Endometriosis: sis in the endometrium of women with ovular dysfunctional uter-
epidemiology and aetiological factors. Best Pract Res Clin Obstet ine bleeding. Br J Obstet Gynaecol. 1981;88(4):434–42.
Gynaecol. 2004;18(2):177–200. 74. Smith SK, Abel MH, Kelly RW, Baird DT. A role for prostacy-
53. Nap AW, Groothuis PG, Demir AY, Evers JLH, Dunselman clin (PGi2) in excessive menstrual bleeding. Lancet (London,
GAJ. Pathogenesis of endometriosis. Best Pract Res Clin Obstet England). 1981;1(8219):522–4.
Gynaecol. 2004;18(2):233–44. 75. Heatley MK. The association between clinical and pathological
54. Signorile PG, Baldi A. Endometriosis: new concepts in the patho- features in histologically identified chronic endometritis. J Obstet
genesis. Int J Biochem Cell Biol. 2010;42(6):778–80. Gynaecol. 2004;24(7):801–3.
55. Mathur S, Peress MR, Williamson HO, et al. Autoimmunity to 76. Pitsos M, Skurnick J, Heller D. Association of pathologic diagno-
endometrium and ovary in endometriosis. Clin Exp Immunol. ses with clinical findings in chronic endometritis. J Reprod Med.
1982;50(2):259–66. 2009;54(6):373–7.
56. Suginami H. A reappraisal of the coelomic metaplasia theory by 77. Toth M, Patton DL, Esquenazi B, Shevchuk M, Thaler H, Divon
reviewing endometriosis occurring in unusual sites and instances. M. Association between chlamydia trachomatis and abnormal
Am J Obstet Gynecol. 1991;165(1):214–8. uterine bleeding. Am J Reprod Immunol. 2007;57(5):361–6.
57. Schrager S, Falleroni J, Edgoose J. Evaluation and treatment of 78. Rosenberg MJ, Waugh MS, Stevens CM. Smoking and cycle
endometriosis. Am Fam Physician. 2013;87(2):107–13. control among oral contraceptive users. Am J Obstet Gynecol.
58. Kodaman PH. Current strategies for endometriosis management. 1996;174(2):628–32.
Obstet Gynecol Clin North Am. 2015;42(1):87–101. 79. Meijer WEE, Heerdink ER, Nolen WA, Herings RMC, Leufkens
59. Suzuki T, Izumi SI, Matsubayashi H, Awaji H, Yoshikata K, Makino HGM, Egberts ACG. Association of risk of abnormal bleeding
T. Impact of ovarian endometrioma on oocytes and pregnancy out- with degree of serotonin reuptake inhibition by antidepressants.
come in in vitro fertilization. Fertil Steril. 2005;83(4):908–13. Arch Intern Med. 2004;164(21):2367.
60. Reeve L, Lashen H, Pacey AA. Endometriosis affects sperm- 80. Marzano DA, Haefner HK. The Bartholin gland cyst: past, pres-
endosalpingeal interactions. Hum Reprod. 2005;20(2):448–51. ent, and future. J Low Genit Tract Dis. 2004;8:195.
61. American Fertility Society. Revised American Fertility Society clas- 81. Krissi H, Shmuely A, Aviram A, From A, Edward R, Peled
sification of endometriosis: 1985. Fertil Steril. 1985;43(3):351–2. Y. Acute Bartholin’s abscess: microbial spectrum, patient charac-
62. Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal teristics, clinical manifestation, and surgical outcomes. Eur J Clin
anti-inflammatory drugs for pain in women with endometriosis Microbiol Infect Dis. 2016;35(3):443–6.
(Review). 2010;(2). www.cochranelibrary.com. 82. Downs MC, Randall HW Jr. The ambulatory surgical manage-
63. Jacobson T, Duffy JMN, Barlow D, Konincks PR, Garry ment of Bartholin duct cysts. J Emerg Med. 1989;7:623–6.
R. Laparoscopic surgery for pelvic pain associated with endome- 83. Cobellis PL, Stradella L, De Lucia E, et al. Alcohol sclerother-
triosis. Cochrane Libr. 2010;(11):1–21. apy: a new method for Bartholin gland cyst treatment. Minerva
64. Jones KD, Sutton C. Patient satisfaction and changes in pain Ginecol. 2006;58:245–8.
scores after ablative laparoscopic surgery for stage III-IV endome- 84. Kafali H, Yurtseven S, Ozardali I. Aspiration and alcohol sclero-
triosis and endometriotic cysts. Fertil Steril. 2003;79(5):1086–90. therapy: a novel method for management of Bartholin’s cyst or
65. Munro MG, Critchley HOD, Broder MS, Fraser IS. FIGO clas- abscess. Eur J Obstet Gynecol Reprod Biol. 2004;112:98–101.
sification system (PALM-COEIN) for causes of abnormal uterine 85. Cheetham DR. Bartholin’s cyst: marsupialization or aspiration?
bleeding in nongravid women of reproductive age. Int J Gynecol Am J Obstet Gynecol. 1985;152:569–70.
Obstet. 2011;113(1):3–13. 86. Gennis P, Li SF, Provataris J, et al. Jacobi ring catheter treatment
66. Lieng M, Istre O, Sandvik L, Qvigstad E. Prevalence, 1-Year of Bartholin’s abscesses. Am J Emerg Med. 2005;23:414–5.
regression rate, and clinical significance of asymptomatic endo- 87. Andersen PG, Christensen S, Detlefsen GU, et al. Treatment
metrial polyps: cross-sectional study. J Minim Invasive Gynecol. of Bartholin’s abscess. Marsupialization versus incision,
2009;16(4):465–71. curettage and suture under antibiotic cover. A randomized
67. Anastasiadis PG, Koutlaki NG, Skaphida PG, Galazios GC, study with 6 months’ follow up. Acta Obstet Gynecol Scand.
Tsikouras PN, Liberis VA. Endometrial polyps: prevalence, detec- 1992;71:59–62.
tion, and malignant potential in women with abnormal uterine 88. Penna C, Fambrini M, Fallani MG. CO2 laser treatment for
bleeding. Eur J Gynaecol Oncol. 2000;21(2):180–3. Bartholin’s gland cyst. Int J Gynaecol Obstet. 2002;76:79–80.
68. Wamsteker K, Emanuel MH, de Kruif JH. Transcervical hys- 89. Benedetti Panici P, Manci N, Bellati F, et al. CO2 laser ther-
teroscopic resection of submucous fibroids for abnormal uterine apy of the Bartholin’s gland cyst: surgical data and functional
510 A. Ragusa et al.
short- and long-term results. J Minim Invasive Gynecol. 112. Butwick AJ. Postpartum hemorrhage and low fibrinogen levels:
2007;14:348–51. the past, present and future. Int J Obstet Anesth. 2013;22(2):
90. Fambrini M, Penna C, Pieralli A, et al. Carbon-dioxide laser 87–91.
vaporization of the Bartholin gland cyst: a retrospective analysis 113. Edwards P, Shakur H, Barnetson L, et al. Central and sta-
on 200 cases. J Minim Invasive Gynecol. 2008;15:327–31. tistical data monitoring in the Clinical Randomisation of an
91. World Health Organization. Guidelines for medico-legal care of Antifibrinolytic in Significant Haemorrhage (CRASH-2) trial.
victims of sexual violence, 2003. Clin Trials. 2014;11(3):336–43.
92. Ellsberg M, Jansen HA, Heise L, Watts CH, Garcia-Moreno C, 114. Lalonde A, International Federation of Gynecology and
WHO Multi-Country Study on Women’s Health and Domestic Obstetrics. Prevention and treatment of postpartum hem-
Violence Against Women Study Team. Intimate partner violence orrhage in low-resource settings. Int J Gynaecol Obstet.
and women’s physical and mental health in the WHO multicountry 2012;117(2):108–18.
study on women’s health and domestic violence: an observational 115. AIFA. Nota informativa importante concordata con l’EMA
study. Lancet. 2008;371(9619):1165–72. https://doi.org/10.1016/ e l’AIFA: Restrizione d’uso di HES (medicinali contenenti
S0140-6736(08)60522-X. amido idrossietilico). 2013. http://www.agenziafarmaco.gov.
93. UK National Guidelines on the Management of Adult and it/it/content/nota-informativa-importante-sulla-restrizione-
Adolescent Complainants of Sexual Assault; 2011. d%E2%80%99uso-di-hes-medicinali-contenenti-amido-idros.
94. Ragusa A, Crescini C. URGENZE ED EMERGENZE IN SALA Last accessed 06 Jun 2017.
PARTO. Padova: Casa Editrice PICCIN Nuova Libreria; 2015. 116. Charbit B, Mandelbrot L, Samain E, et al. The decrease of fibrino-
p. 197–211. gen is an early predictor of the severity of postpartum hemorrhage.
95. Oyelese Y, Ananth CV. Placental Abruptio. Obstet Gynecol. J Thromb Haemost. 2007;5(2):266–73.
2006;108(4):1005–16. 117. Collins PW, Lilley G, Bruynseels D, et al. Fibrin-based clot for-
96. Yeo L, Vintzleos A. Placenta Abruptio. Philadelphia: Lippincott, mation an early and rapidly available biomarker for progression
Williams & Wilkins; 2004. of postpartum hemorrhage: a prospective cohort study. Blood.
97. Royal College of Obstetricians and Gynaecologists. Antepartum 2014;124(11):1727–36.
haemorrhage. RCOG 2011. Green-top guidelines N° 63. 118. Kozek-Langenecker SA, Afshari A, Albaladejo P, et al.
98. Tikkanen M. Etiology, clinical manifestations, and predic- Management of severe perioperative bleeding: guidelines from
tion of placental abruption. Acta Obstet Gynecol Scand. the European Society of Anaesthesiology. Eur J Anaesthesiol.
2010;89(6):732–40. 2013;30(6):270–382.
99. Glantz C, Purnell L. Clinical utility of sonography in the diag- 119. Hofmeyr GJ, Abdel-Aleem H, Abdel-Aleem MA. Uterine mas-
nosis and treatment of placental abruption. J Ultrasound Med. sage for preventing postpartum haemorrhage. Cochrane Database
2002;21(8):837–40. Syst Rev. 2013;(7):CD006431.
100. Usui R, Matsubara S, Ohkuchi A, Kuwata T, Watanabe T, Izumi A, 120. Allam MS, B-Lynch C. The B-Lynch and other uter-
et al. Fetal heart pattern reflecting the severity of placental abrup- ine compression suture techniques. Int J Gynecol Obstet.
tion. Arch Gynecol Obstet. 2008;277(3):249–53. 2005;89(3):236–41.
101. Oyelese Y, Smulian JC. Placenta previa, placenta accreta and vasa 121. B-Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch
previa. Obstet Gynecol. 2006;107(4):927–41. surgical technique for the control of massive postpartum haemor-
102. Royal College of Obstetricians and Gynaecologists. Placenta rhage: an alternative to hysterectomy? Five cases reported. Br J
praevia, placenta praevia accreta and vasa praevia: diagnosis and Obstet Gynaecol. 1997;104(3):372–5.
management. RCOG 2011. Green-top guidelines N° 27. 122. Baskett TF. Uterine compression sutures for postpartum hemor-
103. WHO recommendations for the prevention and treatment of rhage: efficacy, morbidity, and subsequent pregnancy. Obstet
postpartum haemorrhage. 2012. http://apps.who.int/iris/bitstr Gynecol. 2007;110(1):68–71.
eam/10665/75411/1/9789241548502_eng.pdf. Last accessed 06 123. Price N, B-Lynch C. Technical description of the B-Lynch
Jun 2017. brace suture for treatment of massive postpartum hemorrhage
104. Royal College of Obstetricians and Gynaecologists (RCOG). and review of the published cases. Int J Fertil Womens Med.
Prevention and management of postpartum haemorrhage. Green- 2005;50(4):148–63.
top Guideline N. 52. 2009. https://www.rcog.org.uk/en/guidelines- 124. Hayman RG, Arulkumaran S, Steer PJ. Uterine compression
research-services/guidelines/gtg52/. Last accessed 06 Jun 2017. sutures: surgical management of postpartum hemorrhage. Obstet
105. Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Gynecol. 2002;99(3):502–6.
Z. Treatment for primary postpartum haemorrhage. Cochrane 125. Ghezzi F, Cromi A, Uccella S, Raio L, Bolis P, Surbek D. The
Database Syst Rev. 2014;(2):CD003249. Hayman technique: a simple method to treat postpartum haemor-
106. Mukherjee S, Sabaratnam A. Post-partum haemorrhage. Obstet rhage. BJOG. 2007;114(3):362–5.
Gynaecol Reprod Med. 2009;19:121–16. 126. Joshi VM, Otiv SR, Majumder R, Nikam YA, Shirivastava
107. Meir JY, Natale N, Arisi E, et al. Emorragia post-partum: linee guida M. Internal iliac artery ligation for arresting postpartum haemor-
per la prevenzione, Diagnosi e il trattamento. Linee guida AOGOI. I rhage. BJOG. 2007;114(3):356–61.
libri dell’AOGOI. Cento, Ferrara: Editeam; 2009. p. 23–49 127. Lethaby A, Mukhopadhyay A, Naik R. Total versus subtotal
108. Abdul-Kadir R, McLintock C, Ducloy AS, et al. Evaluation and hysterectomy for benign gynaecological conditions. Cochrane
management of postpartum hemorrhage: consensus from an inter- Database Syst Rev. 2012;(4):CD004993.
national expert panel. Transfusion. 2014;54(7):1756–68. 128. Grady K, Howell C, Cox C. Uterine inversion - chapter23. In:
109. Pavord S, Maybury H. How I treat postpartum hemorrhage. Blood. The MOET coursemanual: managing obstetric emergencies and
2015;125(18):2759–70. trauma. 2nd ed. London: RCOG Press; 2007.
110. Ducloy-Bouthors AS, Jude B, Duhamel A, et al. High-dose 129. Loeffler F. Postpartum haemorrhge and abnormalities of the
tranexamic acid reduces blood loss in postpartum haemorrhage. third stage of labour. In: Chamberlain G, editor. Turnbull’s
Crit Care. 2011;15(2):R117. obstetrics. 2nd ed. Edinburgh: Churchill Livingstone; 1995.
111. Sentilhes L, Deneux-Tharaux C. Prophylactic tranexamic acid in p. 729–34.
addition to uterotonics may prevent blood loss for vaginal and cae- 130. O’Sullivan J. Acute inversion of the uterus. Br Med J. 1945;2:
sarean deliveries. Evid Based Med. 2016;21(3):97. 282–3.
33 Updates in the Management of Ob-Gyn Emergencies 511
131. Ragusa A, Crescini C, et al. Uterine inversion- Chapter 11. In: 155. Kuhlmann RS, Cruikshank DP. Maternal trauma during preg-
Manuale di urgenze ed emergenze in sala parto. 2nd ed. Padova: nancy. Clin Obstet Gynecol. 1994;37(2):274–93.
Piccin Press; 2016. 156. Petrone P, Talving P, Browder T, Teixeira PG, Fisher O, Lozornio
132. Shah-Hosseini R, Evrard JR. Puerperal uterine inversion. Obstet A, et al. Abdominal injuries in pregnancy: a 155-month study at
Gynecol. 1989;73(4):567–70. two level 1 trauma centers. Injury. 2011;42(1):47–9.
133. Watson P, Besch N, Bowes WA Jr. Management of acute and 157. Vikram K, Parul G, Ranjana K, Umamaheshwar K. Trauma
subacute puerperal inversion of the uterus. Obstet Gynecol. in pregnancy - a review. Adv Res Gastroenterol Hepatol.
1980;55(1):12–6. 2016;2(1):555580.
134. Soleymani Majd H, Pilsniak A, Reginald PW. Recurrent uterine 158. Suresh MS, Wali A. Failed intubation in obstetrics: airway man-
inversion: a novel treatment approach using SOS Bakri balloon. agement strategies. Anesthesiol Clin North Am. 1998;16:477–98.
BJOG. 2009;116(7):999–1001. 159. Ramsay G, Paglia M, Bourjeily G. When the heart stops: a
135. Huntington JL, Irving FC, Kellog FS. Abdominal reposition in review of cardiac arrest in pregnancy. J Intensive Care Med.
acute inversion of the puerperal uterus. Am J Obstet Gynecol. 2013;28(4):204–14.
1928;15:34–40. 160. Lockey DJ, Crewdson K, Lossius HM. Pre-hospital anaesthesia:
136. Boyle JJ, Katz VL. Umbilical cord prolapse in current obstetric the same but different. Br J Anaesth. 2014;113(2):211–9.
practice. J Reprod Med. 2005;50(5):303–6. 161. Pearlman M, Faro S. Obstetric septic shock: a pathophysiologic
137. Draycott T, Winter C, Crofts J, et al., editors. Module 8. Cord pro- basis for management. Clin Obstet Gynecol. 1990;33(3):482–92.
lapse in: PROMPT: practical obstetric multi professional training 162. American College of Surgeons Committee: on Trauma. Trauma
course manual. London: RCOG Press; 2008. p. 117–24. in women. In: Advanced trauma life support for doctors: student
138. Goswami K. Umbilical cord prolapse. In: Grady K, Howell C, Cox course manual. 9th ed. Chicago, Surgeons. 2012;9:259–68.
C, editors. Managing obstetric emergencies and trauma. The MOET 163. Epstein FB. Acute abdominal pain in pregnancy. Emerg Med Clin
course manual. 2nd ed. London: RCOG Press; 2007. p. 233–7. North Am. 1994;12(1):151–65.
139. Koonings PP, Paul RH, Campbell K. Umbilical cord prolapse. A 164. Puri A, Khadem P, Ahmed S, Yadav P, Al-Dulaimy K. Imaging
contemporary look. J Reprod Med. 1990;35(7):690–2. of trauma in a pregnant patient. Semin Ultrasound CT MR.
140. Panter KR, Hannah ME. Umbilical cord prolapse: so far so good? 2012;33(1):37–45.
Lancet. 1996;347(8994):74. Royal College of Obstetricians and 165. Donnelly EH, Smith JM, Farfán EB, Ozcan I. Prenatal radiation
Gynaecologists. Umbilical cord prolapse. Green-top Guideline exposure: background material for counseling pregnant patients
No.50; April 2008. following exposure to radiation. Disaster Med Public Health Prep.
141. Siassakos D, Crofts JF, Winter C, Weiner CP, Draycott TJ. The 2011;5(1):62–8.
active components of effective training in obstetric emergencies. 166. De Santis M, Di Gianantonio E, Straface G, Cavaliere AF, Caruso
BJOG. 2009;116(8):1028–32. A, Schiavon F, et al. Ionizing radiations in pregnancy and terato-
142. Usta IM, Mercer BM, Sibai BM. Current obstetrical prac- genesis: a review of literature. Reprod Toxicol. 2005;20(3):323–9.
tice and umbilical cord prolapse. Am J Perinatol. 1999;16(9): 167. Patel SJ, Reede DL, Katz DS, Subramaniam R, Amorosa
479–84. JK. Imaging the pregnant patient for nonobstetric conditions:
143. Murphy DJ, MacKenzie IZ. The mortality and morbidity asso- algorithms and radiation dose considerations. Radiographics.
ciated with umbilical cord prolapse. Br J Obstet Gynaecol. 2007;27(6):1705–22.
1995;102(10):826–30. 168. Ray JG, Schull MJ, Urquia ML, You JJ, Guttmann A, Vermeulen
144. Lin MG. Umbilical cord prolapse. Obstet Gynecol Surv. MJ, Franco EL, Academic Editor. Major radiodiagnostic imaging
2006;61(4):269–77. in pregnancy and the risk of childhood malignancy: a population-
145. Katz Z, Shoham Z, Lancet M, Blickstein I, Mogilner BM, Zalel based cohort study in Ontario. PLoS Med. 2010;7(9):e1000337.
Y. Management of labor with umbilical cord prolapse: a 5-year Published online 7 Sept 2010. https://doi.org/10.1371/journal.
study. Obstet Gynecol. 1988;72(2):278–81. pmed.1000337.
146. Crofts JF, Ellis D, Draycott TJ, Winter C, Hunt LP, Akande 169. Sagiv R, Debby A, Feit H, Cohen-Sacher B, Keidar R,
VA. Change in knowledge of midwives and obstetricians follow- Golan A. The optimal cutoff serum level of human chori-
ing obstetric emergency training: a randomized controlled trial of onic gonadotropin for efficacy of methotrexate treatment in
local hospital, simulation centre and teamwork training. BJOG. women with extrauterine pregnancy. Int J Gynaecol Obstet.
2007;114(12):1534–41. 2012;116(2):101–4.
147. Siassakos D, Fox R, Draycott TJ. Umbilical cord prolapse [Green- 170. Abe T, Akira S, Negishi Y, Ichikawa M, Nakai A, Takeshita
top guideline no. 50]. London: RCOG Press; 2008. T. Relevance of declines in serum human chorionic gonadotropin
148. Siassakos D, Hasafa Z, Sibanda T, Fox R, Donald F, Winter C, levels to the management of persistent ectopic pregnancy. J Obstet
et al. Retrospective cohort study of diagnosis-delivery interval Gynaecol Res. 2009;35(5):961–6.
with umbilical cord prolapse: the effect of team training. BJOG. 171. Hajenius PJ, Mol F, Mol BW, Bossuyt PM, Ankum WM, van
2009;116(8):1089–96. der Veen F. Interventions for tubal ectopic pregnancy. Cochrane
149. Khandelwal A, Fasih N, Kielar A. Imaging of acute abdomen in Database Syst Rev. 2007.
pregnancy. Radiol Clin North Am. 2013;51:1005–22. 172. Diagnosis and management of ectopic pregnancy. Green‐top guide-
150. Germain A, Brunaud L. Visceral surgery and pregnancy. J Visc line no. 21. 2016;123(13):e15–55. https://doi.org/10.1111/1471-
Surg. 2010;147:e129–35. 0528.14189. First published: 3 Nov 2016.
151. Gilo NB, Amini D, Landy HJ. Appendicitis and cholecystitis in 173. Choudhary N, Saha SC, Gopalan S. Abortion procedures in a
pregnancy. Clin Obstet Gynecol. 2009;52:586–96. tertiary care institution in India. Int J Gynaecol Obstet. 2005;91:
152. ACOG Committee on Obstetric Practice. ACOG Committee 81–6.
Opinion No. 474: Non obstetric surgery during pregnancy. Obstet 174. Steinauer JE, Diedrich JT, Wilson MW, Darney PD, Vargas JE,
Gynecol. 2011;117:420–1. Drey EA. Uterine artery embolization in postabortion hemor-
153. Evans SR, Sarani B, Bhanot P, Feldman E. Surgery in pregnancy. rhage. Obstet Gynecol. 2008;111:881–9.
Curr Probl Surg. 2012;49:333–88. 175. O’Connell K, Jones H, Simon M, Saporta V, Paul M, Lichtenberg
154. Knab LM, Boller AM, Mahvi DM. Cholecystitis. Surg Clin North E. First-trimester surgical abortion practices: a survey of National
Am. 2014;94:455–70. Abortion Federation members. Contraception. 2009;79:385–92.
512 A. Ragusa et al.
176. O’Connell K, Jones HE, Lichtenberg ES, Paul M. Second- 179. Frick AC, Drey EA, Diedrich JT, Steinauer JE. Effect of prior
trimester surgical abortion practices: a survey of National Abortion cesarean delivery on risk of second-trimester surgical abortion
Federation members. Contraception. 2008;78:492–9. complications. Obstet Gynecol. 2010;115:760.
177. Tang O, Schweer H, Seyberth H, Lee S, Ho P. Pharmacokinetics 180. Olamijulo J, Doufekas K. Intrauterine balloon tamponade for
of different routes of administration of misoprostol. Hum Reprod. uncontrollable bleeding during first trimester surgical termination
2002;17:332–6. of pregnancy. J Obstet Gynaecol. 2007;27:440–1.
178. Meckstroth K, Whitaker A, Bertisch S, Goldberg A, Darney
P. Misoprostol administered by epithelial routes: drug absorption
and uterine response. Obstet Gynecol. 2006;108:582–90.